Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Finax: Cheap Buy Cod
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Tysabri screening test may be unreliable
Cannabis and Cannabinoids (PDQ®)
Cost of disorders of the brain in Spain.
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
Relationship between vitamin D and depression in multiple sclerosis.
Experimental autoimmune encephalomyelitis.
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
How to treat tumefactive demyelinating disease?
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Telephone counseling and home telehealth monitoring to improve medication adherence: Results of a pilot trial among individuals with multiple sclerosis.
[American Academy of Neurology, Washington, 18-25 April 2015].
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
PLA2G6 mutations and other rare causes of Neurodegeneration with Brain Iron Accumulation.
Aging, widowhood, multiple sclerosis, and a dog.
Heat Shock Protein 70: Roles in Multiple Sclerosis.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
A nurse-led mental health service for people with multiple sclerosis.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor
Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »
